Pharma
Curai Health was born from a deeply personal place. Co-founder Neal Khosla, along with Xavier Amatriain, launched the company in 2017 with the goal of making healthcare accessible for everyone. Having witnessed close family members struggle through the complexities of chronic illnesses, Khosla knew the gaps in the healthcare system firsthand. His experiences revealed both the strengths and weaknesses of healthcare and sparked a mission to bring accessible primary care to billions worldwide. As Khosla put it, “When you see the system up close, you see the good and you see the bad, and I think it just builds a real connection to why we need to change this problem.”
The name "Curai" itself speaks to their mission, rooted in the concept of "curing" and healing. But the team wasn’t interested in merely treating symptoms; they wanted to create a transformative approach to healthcare that would address the global challenge of healthcare access. Curai’s core goal was clear: scale top-tier healthcare to everyone on Earth by combining the expertise of physicians with the efficiencies of artificial intelligence. As Khosla succinctly put it, “Our mission and the reason we started this company was this idea of how do you build a world where eight billion people have access to really great primary health care.”
Supported by substantial venture capital backing, Curai raised over $50 million in funding from high-profile investors like General Catalyst, Morningside Ventures, and Khosla Ventures, the latter founded by Neal Khosla’s father, Vinod Khosla. Although specific valuation figures remain undisclosed, this robust investment speaks to the faith in Curai’s potential to reshape healthcare.
